Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples

被引:0
|
作者
Pedersen, Kathrine [1 ]
Laursen, Nick Stub [1 ,2 ]
Hansen, Annette Gudmann [1 ]
Palarasah, Yaseelan [3 ]
Thiel, Steffen [1 ]
机构
[1] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[2] Commit Biol, Aarhus, Denmark
[3] Univ Southern Denmark, Dept Mol Med, Odense, Denmark
基金
新加坡国家研究基金会;
关键词
Soluble CD40L; CD154; CD40:CD40L pathway; Immunoassay; Biomarker; LIGAND; LUPUS; EXPRESSION; MECHANISM; CELLS;
D O I
10.1016/j.jim.2024.113710
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
When the membrane protein CD40 ligand (CD40L) on activated T cells binds the receptor CD40 on B-cells, it provides a co-stimulatory signal for B cell activation. Dysregulation of the CD40L:CD40 axis is associated with inflammatory and autoimmune diseases. The presence of soluble CD40L (sCD40L) in plasma is implicated in several diseases, from cardiovascular and autoimmune diseases to different types of cancer, and sCD40L has been suggested as a valuable marker of disease. If sCD40L is to be used as a biomarker, being able to precisely measure and quantify the levels of sCD40L in human blood samples is of utmost importance. We demonstrate the development of a sandwich-type time-resolved immunofluorometric assay for quantification of sCD40L in plasma or serum samples. For this, we generate 29 monoclonal anti-CD40L antibodies, and from these, we select the optimal combination of capture antibody and detection antibody. A number of variables were tested: the influence of the type of sample (comparing 3 different blood collection tubes for serum sampling and 4 different types of tubes for plasma sampling), the influence of freeze-thaw cycles, the influence of sampling time during night and day, and the influence of centrifugation of the samples. We found a very similar level of sCD40L in paired EDTA plasma and serum samples. Out of 100 healthy blood donor samples 61 had a level of sCD40L below the detection level of the assay, whereas the remaining 39 samples had ranging levels of sCD40L from 1.14 to 33.14 ng/mL. In summary, we present a time-resolved immunofluorometric assay based on paired monoclonal antibodies, ensuring high specificity, sensitivity, and homogeneity. The Eu3+-based assay additionally provides consistent assay readouts due to the extended decay time not seen in standard enzyme-linked immunosorbent assays. The assay paves the way for specific and consistent quantification of sCD40L in human plasma and serum samples.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The role of soluble CD40L in immunosuppression
    Schlom, Jeffrey
    Jochems, Caroline
    Gulley, James L.
    Huang, Jianping
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [42] Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L
    Fan, Y
    Ge, Y
    Zhu, H
    Wang, Y
    Yang, B
    Zhuang, Y
    Ma, H
    Zhang, X
    TISSUE ANTIGENS, 2004, 64 (03): : 257 - 263
  • [43] An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions
    Blumberg, Neil
    Gettings, Kelly F.
    Turner, Chantal
    Heal, Joanna M.
    Phipps, Richard P.
    TRANSFUSION, 2006, 46 (10) : 1813 - 1821
  • [44] Autoimmune thrombocytopenia: Flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes
    Meabed, Mohamed H.
    Taha, Gamal M.
    Mohamed, Seham O.
    El-Hadidy, Khaled S.
    HEMATOLOGY, 2007, 12 (04) : 301 - 307
  • [45] Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity
    Chung, I.
    Choudhury, A.
    Patel, J.
    Lip, G. Y. H.
    JOURNAL OF INTERNAL MEDICINE, 2008, 263 (03) : 313 - 321
  • [46] Soluble CD40L in systemic lupus erythematosus
    Alexandrova, EN
    Novikov, AA
    Popkova, TV
    Novikova, DS
    Klukvina, NG
    Nasonov, EL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 134 - 134
  • [47] Platelet and soluble CD40L in meningococcal sepsis
    Inwald, David P.
    Faust, Saul N.
    Lister, Paula
    Peters, Mark J.
    Levin, Michael
    Heyderman, Robert
    Klein, Nigel J.
    INTENSIVE CARE MEDICINE, 2006, 32 (09) : 1432 - 1437
  • [48] Soluble CD40L and cardiovascular risk in women
    Schönbeck, U
    Varo, N
    Libby, P
    Buring, J
    Ridker, PM
    CIRCULATION, 2001, 104 (19) : 2266 - 2268
  • [49] Effect of platelet transfusion on plasma CD40L and on CD40L release capacity in the peripheral blood
    Wenzel, F.
    Guenther, W.
    Haas, R.
    Giers, G.
    ONKOLOGIE, 2011, 34 : 240 - 240
  • [50] Evaluation of soluble CD40L measurements.
    Varo, N
    Nuzzo, R
    Libby, P
    Schönbeck, U
    CLINICAL CHEMISTRY, 2004, 50 (06) : A112 - A112